← Open Payments lookup

JAMES SHEPPARD: Open Payments

NPI 1528075835 · THOMSON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$872 in 45 payments from 15 companies in 2025. Trend: 2023 $370 · 2024 $669 · 2025 $872

Food & beverage: $872
CompanyPaymentsAmount
ABBVIE INC.17$182
AstraZeneca Pharmaceuticals LP1$149
Bayer Healthcare Pharmaceuticals Inc.4$92
Lilly USA, LLC4$71
Novo Nordisk Inc3$59
Verona Pharma, Inc.2$47
Otsuka America Pharmaceutical, Inc.2$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$40
PFIZER INC.2$40
UCB, Inc.1$33

Products named: AIRSUPRA, VRAYLAR, Kerendia, MOUNJARO, Ozempic, Ohtuvayre, REXULTI, CAPLYTA.

Industry payments across GA — which companies pay providers there.